发明授权
US6068841A Antibodies to Fas-L for treatment of hepatitis 失效
Fas-L抗体用于治疗肝炎

Antibodies to Fas-L for treatment of hepatitis
摘要:
The invention provides therapeutic agents for hepatitis, comprising an antibody against a human Fas ligand, or an active fragment thereof as an active ingredient. The therapeutic agents for hepatitis according to the invention are particularly effective for the treatment of hepatitis caused by the death of hepatocytes due to apoptosis among many kinds of hepatitis.
公开/授权文献
信息查询
0/0